Most cited papers in Antibiotics Pharmacokinetics and Efficacy
What are the most cited papers in Antibiotics Pharmacokinetics and Efficacy?
The most cited paper in Antibiotics Pharmacokinetics and Efficacy is "Antibiotic resistance—the need for global solutions" (Ramanan Laxminarayan et al., 2013), with 4,516 citations. Next come "Antibiotics in the aquatic environment – A review – Part I" (4,483) and "Determination of minimum inhibitory concentrations" (4,142).
Showing 50 of 100 papers. Every paper with more than 938 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Antibiotic resistance—the need for global solutions Ramanan Laxminarayan et al. · The Lancet Infectious Diseases | 16 Nov 2013 | 4,516 |
| 2 | Antibiotics in the aquatic environment – A review – Part I Klaus Kümmerer · Chemosphere | 31 Jan 2009 | 4,483 |
| 3 | Determination of minimum inhibitory concentrations Jennifer M. Andrews · Journal of Antimicrobial Chemotherapy | Jul 2001 | 4,142 |
| 4 | Extended-Spectrum β-Lactamases: a Clinical Update David L. Paterson, Robert A. Bonomo · Clinical Microbiology Reviews | Oct 2005 | 3,505 |
| 5 | Occurrence of drugs in German sewage treatment plants and rivers Thomas A. Ternes · Water Research | Nov 1998 | 3,419 |
| 6 | CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database Brian P. Alcock et al. · Nucleic Acids Research | 8 Oct 2019 | 3,385 |
| 7 | A Novel Method for Measuring Antioxidant Capacity and its Application to Monitoring the Antioxidant Status in Premature Neonates Nicholas J. Miller, Catherine A Rice-Evans, Michael J. Davies et al. · Clinical Science | Apr 1993 | 3,129 |
| 8 | Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release Nazila Kamaly, Basit Yameen, Jun Hua Wu et al. · Chemical Reviews | 8 Feb 2016 | 3,033 |
| 9 | Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study Kanimozhi Kumarasamy et al. · The Lancet Infectious Diseases | 11 Aug 2010 | 2,938 |
| 10 | State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men William A. Craig · Clinical Infectious Diseases | 1998 | 2,920 |
| 11 | Mechanisms of Antibiotic Resistance Jose Manuel Munita, César A. Arias · Microbiology Spectrum | 25 Mar 2016 | 2,653 |
| 12 | Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review Luigi Rizzo, Célia M. Manaia, Christophe Merlin et al. · The Science of The Total Environment | 7 Feb 2013 | 2,501 |
| 13 | A pharmacokinetic analysis program (multi) for microcomputer. Kiyoshi Yamaoka, Yusuke Tanigawara, Terumichi Nakagawa et al. · Journal of Pharmacobio-Dynamics | 1981 | 2,459 |
| 14 | A Sensitive and Quick Microplate Method to Determine the Minimal Inhibitory Concentration of Plant Extracts for Bacteria Jacobus Nicolaas Eloff · Planta Medica | Dec 1998 | 2,332 |
| 15 | A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS Robert W. Guthrie, Ada Susi · PEDIATRICS | Sep 1963 | 2,243 |
| 16 | Occurrence of antibiotics in the aquatic environment Roman Hirsch, Thomas A. Ternes, Klaus Haberer et al. · The Science of The Total Environment | 1999 | 2,141 |
| 17 | PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel Yong Zhang, Meirong Huo, Jianping Zhou et al. · Computer Methods and Programs in Biomedicine | 22 Feb 2010 | 2,091 |
| 18 | Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations Kiyoshi Yamaoka, Terumichi Nakagawa, Toyozo Uno · Journal of Pharmacokinetics and Biopharmaceutics | Apr 1978 | 2,079 |
| 19 | 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer Walter T. Hughes, Donald Armstrong, Gerald P. Bodey et al. · Clinical Infectious Diseases | 15 Mar 2002 | 1,980 |
| 20 | DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs Yves G. Pommier, Elisabetta Leo, Hongliang Zhang et al. · Chemistry & Biology | May 2010 | 1,865 |
| 21 | Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists Michael Joseph Rybak, Ben M. Lomaestro, John C. Rotschafer et al. · American Journal of Health-System Pharmacy | 23 Dec 2008 | 1,808 |
| 22 | Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011 Katherine E. Fleming-Dutra et al. · JAMA | 3 May 2016 | 1,763 |
| 23 | Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections M. E. Falagas, S. K. Kasiakou, Louis Donald Saravolatz · Clinical Infectious Diseases | 15 Apr 2005 | 1,749 |
| 24 | beta-Lactamases in laboratory and clinical resistance David M. Livermore · Clinical Microbiology Reviews | Oct 1995 | 1,744 |
| 25 | Quinoline, quinazoline and acridonealkaloids Joseph P. Michael · Natural Product Reports | 17 Dec 2007 | 1,721 |
| 26 | Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases Luisa Silvia Munoz-Price et al. · The Lancet Infectious Diseases | 19 Aug 2013 | 1,682 |
| 27 | Three Decades of β-Lactamase Inhibitors Sarah M. Drawz, Robert A. Bonomo · Clinical Microbiology Reviews | 2010 | 1,676 |
| 28 | Molecular Mechanisms of Antibacterial Multidrug Resistance Michael N. Alekshun, Stuart B. Levy · Cell | Mar 2007 | 1,666 |
| 29 | Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae Hesna Yigit, Anne Marie Queenan, Gregory Jon Anderson et al. · Antimicrobial Agents and Chemotherapy | Apr 2001 | 1,650 |
| 30 | The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria Xian-Zhi Li, Patrick Plésiat, Hiroshi Nikaido · Clinical Microbiology Reviews | 18 Mar 2015 | 1,646 |
| 31 | Guidelines for the Evaluation and Management of Status Epilepticus Gretchen M. Brophy, RODNEY D. BELL, Jan Claassen et al. · Neurocritical Care | 23 Apr 2012 | 1,630 |
| 32 | Carbamazepine and diclofenac: Removal in wastewater treatment plants and occurrence in water bodies Yongjun Zhang, Sven‐Uwe Geißen, Carmen Gal · Chemosphere | 16 Sep 2008 | 1,581 |
| 33 | Extended Broad-Spectrum -Lactamases Conferring Transferable Resistance to Newer -Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility Patterns Vincent Jarlier, M. H. Nicolas, Guy Fournier et al. · Clinical Infectious Diseases | Jul 1988 | 1,569 |
| 34 | Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux Hiroshi Nikaido · Science | 15 Apr 1994 | 1,555 |
| 35 | Carbapenems: Past, Present, and Future Krisztina M. Papp‐Wallace, Andrea Endimiani, Magdalena A. Taracila et al. · Antimicrobial Agents and Chemotherapy | 22 Aug 2011 | 1,533 |
| 36 | Multidrug-resistance efflux pumps ? not just for resistance Laura J. V. Piddock · Nature Reviews Microbiology | 17 Jul 2006 | 1,532 |
| 37 | Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition Romney Humphries, April M. Bobenchik, Janet A. Hindler et al. · Journal of Clinical Microbiology | 22 Sep 2021 | 1,517 |
| 38 | Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes Richard Bonnet · Antimicrobial Agents and Chemotherapy | 23 Dec 2003 | 1,494 |
| 39 | Occurrence and toxicity of antibiotics in the aquatic environment: A review Pavla Kovalakova, Leslie H. Cizmas, Thomas J. McDonald et al. · Chemosphere | 6 Mar 2020 | 1,471 |
| 40 | Guidelines for Treatment of Candidiasis Peter G. Pappas, John H. Rex, Jack D. Sobel et al. · Clinical Infectious Diseases | 6 Jan 2004 | 1,453 |
| 41 | Resistance to Antibiotics: Are We in the Post-Antibiotic Era? Alfonso J. Alanis · Archives of Medical Research | 10 Oct 2005 | 1,420 |
| 42 | Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections Jian Li, Roger L. Nation, John D. Turnidge et al. · The Lancet Infectious Diseases | 22 Aug 2006 | 1,412 |
| 43 | Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria Abiola Olumuyiwa Olaitan, Sergé Morand, Jean‐Marc Rolain · Frontiers in Microbiology | 26 Nov 2014 | 1,412 |
| 44 | Multiple Organ Failure Pathophysiology and Potential Future Therapy Edwin A. Deitch · Annals of Surgery | Aug 1992 | 1,393 |
| 45 | β-Lactams and β-Lactamase Inhibitors: An Overview Karen Bush, Patricia A. Bradford · Cold Spring Harbor Perspectives in Medicine | 21 Jun 2016 | 1,364 |
| 46 | Antibiotics in the aquatic environments: A review of the European scenario Isabel Teixeira Carvalho, Lúcia Santos · Environment International | 17 Jul 2016 | 1,325 |
| 47 | Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era Mitchell L. Cohen · Science | 21 Aug 1992 | 1,315 |
| 48 | Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes Manfred Kansy, Frank Senner, Klaus Gubernator · Journal of Medicinal Chemistry | Mar 1998 | 1,307 |
| 49 | Structure of a bacterial multidrug ABC transporter Roger J. P. Dawson, Kaspar P. Locher · Nature | 30 Aug 2006 | 1,301 |
| 50 | Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment Roberto Andreozzi, Raffaele Marotta, Paxéus Nicklas · Chemosphere | 11 Feb 2003 | 1,298 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.